Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | CASP9 | P55211 | 2/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 9/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.39 |
| ▸ | BMP1 | P13497 | 2/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2564476 | 0.89 | BACE1 (0.45) | CASP1CASP3CASP9CASP7BACE1 | |
| SCHEMBL18037135 | 0.88 | CASP1 (0.43) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL29576249 | 0.88 | GNPAT (0.44) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL6534663 | 0.85 | GNPAT (0.54) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL7166591 | 0.85 | GNPAT (0.48) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL22310788 | 0.84 | GNPAT (0.47) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL7157952 | 0.81 | GNPAT (0.44) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL29487532 | 0.81 | GNPAT (0.44) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL31634368 | 0.81 | KDM4E (0.51) | CASP1CASP3CASP9CASP7GNPAT | |
| SCHEMBL2038936 | 0.80 | CASP3 (0.69) | CASP1CASP3CASP9CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090232866-A1 | Oligopeptides as coating material for medical products | HEMOTEQ AG (DE) | 2009-09-17 | — | — | US | claimed |
| JP-2007507264-A | — | — | 2007-03-29 | — | — | JP | claimed |
| EP-1670502-A2 | OLIGOPEPTIDES AS COATING MATERIAL FOR MEDICAL PRODUCTS | Hemoteq GmbH (DE) | 2006-06-21 | — | — | EP | claimed |
| WO-2005039629-A2 | CASPASE INHIBITORS AS COATING MATERIEL FOR MEDICAL PRODUCTS FOR INHIBITING RESTENOSIS | HEMOTEQ GMBH (DE) | 2005-05-06 | — | — | WO | claimed |
| EP-2380586-A2 | Oligopeptides as coating material for medical products | Hemoteq AG (DE) | 2011-10-26 | — | — | EP | disclosed |
| US-8038443-B2 | Fixture mount fixing tool | GC CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20090232866-A1 | Oligopeptides as coating material for medical products | HEMOTEQ AG (DE) | 2009-09-17 | — | — | US | disclosed |
| EP-1670502-A2 | OLIGOPEPTIDES AS COATING MATERIAL FOR MEDICAL PRODUCTS | Hemoteq GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005039629-A2 | CASPASE INHIBITORS AS COATING MATERIEL FOR MEDICAL PRODUCTS FOR INHIBITING RESTENOSIS | HEMOTEQ GMBH (DE) | 2005-05-06 | — | — | WO | disclosed |